In breast cancer, MVC decreased the migration of CCR5+ regulatory T cells, reduced metastatic breast cancer growth in the lungs [55,67], and enhanced cell killing mediated by DNA-damaging chemotherapeutic agents [54]. Here, CCR5 is linked to breast cancer.